Publications (79) Ana María Bajo Chueca publications View referenced research data.

2024

  1. Antagonist of Growth Hormone-Releasing Hormone Receptor MIA-690 Suppresses the Growth of Androgen-Independent Prostate Cancers

    International Journal of Molecular Sciences, Vol. 25, Núm. 20

  2. GHRH and the prostate

    Reviews in Endocrine and Metabolic Disorders

2023

  1. Carbohydrate effect of novel arene Ru(II) phenanthroline-glycoconjugates on metastatic biological processes

    Journal of Inorganic Biochemistry, Vol. 247

  2. Induction of more aggressive tumoral phenotypes in LNCaP and PC3 cells by serum exosomes from prostate cancer patients

    International Journal of Cancer, Vol. 153, Núm. 10, pp. 1829-1841

2022

  1. Tumorigenic transformation of human prostatic epithelial cell line RWPE-1 by growth hormone-releasing hormone (GHRH)

    Prostate, Vol. 82, Núm. 8, pp. 933-941

2020

  1. Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer

    European Journal of Medicinal Chemistry, Vol. 199

  2. Stimulation of neuroendocrine differentiation in prostate cancer cells by GHRH and its blockade by GHRH antagonists

    Investigational New Drugs, Vol. 38, Núm. 3, pp. 746-754

2019

  1. In vitro and in vivo evaluation of first-generation carbosilane arene Ru(II)-metallodendrimers in advanced prostate cancer

    European Polymer Journal, Vol. 113, pp. 229-235

  2. Insight into the antitumor activity of carbosilane Cu(ii)-metallodendrimers through their interaction with biological membrane models

    Nanoscale, Vol. 11, Núm. 28, pp. 13330-13342

  3. Water soluble, optically active monofunctional Pd(II) and Pt(II) compounds: Promising adhesive and antimigratory effects on human prostate PC-3 cancer cells

    Dalton Transactions, Vol. 48, Núm. 38, pp. 14279-14293

2018

  1. Biological evaluation of water soluble arene Ru(II) enantiomers with amino-oxime ligands

    Journal of Inorganic Biochemistry, Vol. 183, pp. 32-42

  2. Does [-2]Pro-Prostate Specific Antigen Meet the Criteria to Justify Its Inclusion in the Clinical Decision-Making Process?

    Urologia Internationalis, Vol. 100, Núm. 2, pp. 146-154

  3. Experiencias de aprendizaje y evaluación colaborativa gamificada mediante iTest

    Educación y compromiso social [Recurso electrónico]: Aprendizaje Servicio (ApS) y otras metodologías

  4. Growth hormone-releasing hormone receptor antagonists modify molecular machinery in the progression of prostate cancer

    Prostate, Vol. 78, Núm. 12, pp. 915-926

  5. Validación del índice de salud prostática en un modelo predictivo de cáncer de próstata

    Actas Urologicas Espanolas, Vol. 42, Núm. 1, pp. 25-32

2017

  1. Growth hormone-releasing hormone (GHRH) promotes metastatic phenotypes through EGFR/HER2 transactivation in prostate cancer cells

    Molecular and Cellular Endocrinology, Vol. 446, pp. 59-69

  2. ITEST, una herramienta gamificada de respuestas y votos para un aprendizaje colaborativo y apoyo a la docencia presencial

    Nuevas apuestas educativas [Recurso electrónico]: entre la docencia presencial y la innovación tecnológica

  3. Nuevos complejos ciclopentadienilo de titanio (IV) con ligandos quirales amino-oxima. Estudio de su efecto in vitro en cáncer de próstata

    Sextas Jornadas de Jóvenes Investigadores de la Universidad de Alcalá: Ciencias e Ingenierías

  4. Ruleta bioquímica: gamificación inmediata para dinamización de la clase presencial

    Nuevas apuestas educativas [Recurso electrónico]: entre la docencia presencial y la innovación tecnológica

2016

  1. Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer

    Oncotarget, Vol. 7, Núm. 32, pp. 52195-52206